MOLECULAR RESEARCH CENTER, LLC – Trademark Portfolio

Entity Type: 16

MOLECULAR RESEARCH CENTER, LLC holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 6 filings in this category. Currently, 6 trademarks are registered. Notable registered marks include DNAZOL, ISOGEN, RNAZOL, TRIZOL, and FORMAZOL. The owner is based in CINCINNATI, OH.

5645 MONTGOMERY ROAD

CINCINNATI, OH 45212

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

RNAZOL
RNAZOL
Registered 1994
DNAZOL
DNAZOL
Registered 1994
ISOGEN
ISOGEN
Registered 1992
FORMAZOL
FORMAZOL
Registered 1992
TRIZOL
TRIZOL
Registered 1992

Trademark Classifications

MOLECULAR RESEARCH CENTER, LLC's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (6 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does MOLECULAR RESEARCH CENTER, LLC have?

MOLECULAR RESEARCH CENTER, LLC has 6 U.S. trademarks filed with the USPTO. Of these, 6 registered.

What trademark classes does MOLECULAR RESEARCH CENTER, LLC file in?

MOLECULAR RESEARCH CENTER, LLC files trademarks across 1 Nice Classification class. The most active classes are Class 1 (Chemicals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are MOLECULAR RESEARCH CENTER, LLC's most well-known trademarks?

MOLECULAR RESEARCH CENTER, LLC's registered trademark portfolio includes well-known marks such as DNAZOL, ISOGEN, RNAZOL, TRIZOL, and FORMAZOL. These are among 6 currently registered trademarks in the portfolio.

What is MOLECULAR RESEARCH CENTER, LLC's trademark registration success rate?

MOLECULAR RESEARCH CENTER, LLC has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.